Case Study: Octapharma USA achieves reliable, compliant EDI transformation and faster go‑live with Cleo

When game-changing integration technology helps deliver life-changing medical treatments

Octapharma USA, a U.S. arm of one of the world’s largest human protein fractionators, needed reliable EDI communications, data transformation, and MFT to ensure regulated pharmaceutical deliveries to hospitals, distributors, and patients. Although Octapharma was already using Cleo for communications, it had outsourced EDI transformation to a VAN that produced a 40% exception rate and forced the team to spend 20–30 hours per week on manual fixes; the migration stalled for 18 months with only five of 14 distributors in production.

Octapharma brought EDI transformation back in‑house by expanding its use of the Cleo Integration Cloud for end-to-end B2B integration. Cleo delivered the required data formats and dependable transport, eliminated downstream manual file sorting, and completed the implementation in three months. As a result, Cleo resolved chronic errors, removed the heavy manual workload, restored compliance and control over the distribution lifecycle, and enabled Octapharma to plan further integration across sales, contracting, finance, and marketing.

Octapharma USA

Michael Donham

Director of IT